US FDA moves Critical Path forward with list of 76 favoured projects
This article was originally published in Clinica
Executive Summary
The FDA yesterday issued its "wish list" of research topics aimed at modernising medical product development, so that new medical discoveries are brought to patients faster and at a lower cost.